Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
Dallas Morning News on MSN18h
FDA adds new warning to weight loss drugs including WegovyWegovy, which is the weight loss version of the drug Ozempic, was the first weight loss drug to receive FDA approval since ...
A dad died just days after using a weight-loss jab so he could ‘confidently walk his daughter down the aisle’, and now his family are demanding answers. Back in 2022, Tim Ramsay decided he wanted to ...
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
The odds for aspiration is greatest in the first weeks after a GLP-1 med is prescribed, since the delay in stomach emptying ...
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
Saxenda is an older drug of the same GLP-1 drug class as the company’s popular Ozempic diabetes treatment and Wegovy weight loss medication. Biocon chief executive officer Siddharth Mittal ...
The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback